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As obligate intracellular parasites, viruses must traverse the host-cell plasma
membrane to initiate infection. This presents a formidable barrier, which they
have evolved diverse strategies to overcome. Common to all entry pathways,
however, is a mechanism of specific attachment to cell-surface macromole-
cules or ‘receptors’. Receptor usage frequently defines viral tropism, and
consequently, the evolutionary changes in receptor specificity can lead to emer-
gence of new strains exhibiting altered pathogenicity or host range. Several
classes of molecules are exploited as receptors by diverse groups of viruses,
including, for example, sialic acid moieties and integrins. In particular, many
cell-adhesion molecules that belong to the immunoglobulin-like superfamily
of proteins (IgSF CAMs) have been identified as viral receptors. Structural
analysis of the interactions between viruses and IgSF CAM receptors has not
shown binding to specific features, implying that the Ig-like fold may not be
key. Both proteinaceous and enveloped viruses exploit these proteins, however,
suggesting convergent evolution of this trait. Their use is surprising given the
usuallyoccludedposition ofCAMson the cell surface, such as at tight junctions.
Nonetheless, the reason for their widespread involvement in virus entry most
probably originates in their functional rather than structural characteristics.
1. Introduction
Fundamentally, viruses are infectious nucleic acids that have evolved efficient
mechanisms for shuttling their genomes between the host cells that they depend
upon for replication. A key stage in the viral replication cycle is cell entry. To
initiate infection, all viruses must traverse the host-cell’s plasma membrane and
in many cases a cell wall. For those viruses that infect animals, the first stage of
this process is attachment to a cell-surface macromolecule, the viral receptor.
There is considerable interest in understanding the virus–receptor interaction at
the structural level. As the first step in the infection process, viral attachment rep-
resents an attractive target for intervention. The process of receptor engagement
leads to initiation of the internalization pathway. Furthermore, receptor binding
is frequently the trigger for conformational changes in the virion itself. These struc-
tural rearrangements are thought to initiate the uncoating process—the controlled,
targeted release of the genome to the site of replication.
2. Viral entry pathways
Viruses employ diverse entry pathways following attachment. The host-cell plasma
membrane presents a significant barrier, penetration ofwhichmay be facilitated by
the presence of a viral membrane or envelope. Enveloped viruses acquire their
membrane from the host either by budding from the plasma membrane of an
infected cell, or by budding into cellular compartments. In either case, the mem-
brane will bear viral glycoproteins that mediate attachment and entry. These
functions may be performed by a single glycoprotein or may be divided between
two or more. Following attachment, the glycoprotein responsible for mediating
cell entry is activated to become fusogenic, undergoing conformational changes
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resulting in insertion of a hydrophobic ‘fusion-peptide’ into the
host-cell plasma membrane. Further structural rearrangements
then bring the viral and cellular membranes together leading
to the formation of a fusion pore. The contents of the virion,
including the encapsidated viral genome (nucleocapsid) are
then delivered into the cytosol.
Not all enveloped viruses initiate fusion at the plasma
membrane. Influenza viruses, for example, enter through the
clathrin-mediated endocytic pathway [1]. Acidification of the
late endosome triggers the activity of the viral fusion protein
haemagglutinin, leading to release of the virion contents into
the cytosol [2]. Endocytosis is also themost commonentrymech-
anism for non-enveloped (proteinaceous) viruses; however, the
manner inwhich these viruses leave the endosome is, in general,
poorly understood. It is thought that this is accomplished either
by the formation of a pore in the endosomal membrane through
which the genome is ejected, or destruction of the endosomal
membrane by viral-encoded gene products [3,4].
3. Receptor usage and viral tropism
Receptor usage is a key factor in defining tropism in many
viruses; for example, influenza viruses bind to sialic acid moi-
eties on the apical surfaces of epithelial cells in the respiratory
tract of mammals or the gut of avian species. These are the pri-
mary sites of viral replication in the respective hosts. Those
viruses that infect humans have evolved to bind a2,6 sialic
acid which is found primarily in the upper respiratory tract.
The haemagglutinin protein of avian viruses, on the other
hand, binds to a2,3 sialic acid, which is the predominant
form in the avian gut epithelium [5]. Thus, evolving to bind dif-
ferently linked sialic acids is thought to be one important step
required for avian viruses to transmit readily between human
hosts. Evolution of receptor usage is therefore a key event
that may lead to emergence of new pathogens with altered
pathogenicity or host ranges.
4. Viral entry via multiple receptor molecules
Binding to sialic acid is awidely used strategy for attachment to
the cell surface in diverse groups of viruses. Indeed, several
classes of receptor molecule have been identified that are
repeatedly found to be used by apparently unrelated viral
species. These include integrins and cell-adhesion molecules
that are members of the immunoglobulin-like superfamily
(IgSF CAMs), the latter being the main focus of this review.
Interestingly, two quite different viruses, feline calicivirus
(FCV) and reovirus, have been found to employ both sialic
acid and the IgSF CAM junctional adhesion molecule A
(JAM-A) [6–9], while the picornavirus encephalomyocarditis
virus binds sialic acid and a different IgSF CAM, vascular
cell-adhesion molecule 1 (VCAM-1) [10,11]. A requirement
for more than one receptor molecule is not uncommon and
many viruses have evolved multi-step attachment processes.
One extreme example is hepatitis C virus (HCV), which has
been shown to require several molecules for cell entry includ-
ing heparan sulfate [12], liver specific intercellular adhesion
molecule-3-grabbing non-integrin (L-SIGN) or dendritic cell
intercellular adhesion molecule-3-grabbing non-integrin (DC-
SIGN) [13–15], low-density lipoprotein receptor (LDL-R)
[16,17], transferrin receptor 1 (TfR1) [18], Niemann-Pick C1-
like protein 1 (NPC1L1) [19], scavenger receptor class B type
I (SR-B1) [20], the tetraspanin CD81 [21] and the tight-junction
components claudin-1 (CLDN-1) [22] and occludin (OCLN)
[23]. SR-B1, CD81, CLDN-1 and OCLN are considered the
minimal requirements for cell entry, while attachment to
L-SIGN is postulated to confer tissue tropism in vivo. Lying
at the centre of the HCV entry pathway is the interaction
between the viral envelope glycoprotein E2 and CD81, which
triggers actin-dependent trafficking of the virus to tight junc-
tions where it comes into contact with CLDN-1 and OCLN,
leading to viral entry by endocytosis.
Trafficking of virus to tight junctions from the apical cell
surface was first demonstrated for group B coxsackie viruses
(CVBs). Many CVBs bind to coxsackievirus and adenovirus
receptor (CAR—an IgSF CAM) as well as the complement
control protein decay-accelerating factor (DAF, also known as
CD55). Clustering of DAF molecules by virus attachment
to the apical cell surface stimulates remodelling of the actin
cytoskeleton by Abl kinase. This, in turn, leads to delivery
of the virus to the tight junction where entry occurs by
caveolin-mediated endocytosis [24].
5. The structure and functions of Ig-like
cell-adhesion molecules
An intriguing aspect of viral receptor usage is the widespread
exploitation of cell-surface glycoproteins that are found pre-
dominantly in intercellular junctions of polarized cells.
Perhaps the most widely used class of adhesion molecule is
the IgSF CAMs (table 1). The immunoglobulin-like superfam-
ily of proteins is characterized as consisting of seven to nine
anti-parallel beta-strands that form two beta-sheets in a
Greek-keymotif, having a barrel shape. The superfamily is sub-
divided according to the number of beta-strands and
topological similarities to the constant (c) or variable (v)
chains of antibodies (V, C1, C2, I). Figure 1a shows the topology
of the V-set Ig-like fold (reviewed in [37]).
JAM-A is a prototypic tight junction associated IgSF CAM
expressed on epithelial and endothelial cells as well as on leu-
cocytes and platelets [38]. It comprises two extracellular Ig-like
domains, a single transmembrane region and a short cyto-
plasmic tail. X-ray crystallography of an ectodomain soluble
fragment of human JAM-A reveals that the N-terminal, mem-
brane-distal D1 domain has nine beta-strands and is therefore
classified as similar to the antibody variable domain (V-set).
The membrane proximal D2 domain, on the other hand, is
classed as I-set, having only eight strands (figure 1b).
Analytical ultracentrifugation analysis of recombinant sol-
uble murine JAM-A revealed that it forms homodimers. Both
murine and human JAM-A crystal structures show a similar
non-covalent interaction between the membrane-distal D1
domains at the GFCC’ face, and this is thought to represent
the dimeric state of JAM-A at the cell surface (figure 1c). Homo-
typic and heterotypic interactions with JAM-A and other
adhesion molecules, respectively, on adjacent cells, are then
thought to regulate tight-junction formation and facilitate
leucocyte transmigration [34,39].
6. Feline calicivirus binding to JAM-A
FCV is one of only a handful of tractable models for the Calici-
viridae, a family of positive-sense RNA containing icosahedral
viruses, which includes norovirus, the cause of winter
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vomiting disease. These small proteinaceous viruses assemble
a T ¼ 3 icosahedral capsid from 90 dimers of a single major
capsid protein VP1 (figure 1d) [35]. The virion is characterized
by the presence of protruding (P) domains that give rise to the
appearance of cups on the surface of the particles when viewed
by negative stain electronmicroscopy; hence their name,which
derives from the Latin calyx.
FCV has been shown to bind to both N-linked a2,6 sialic
acid and feline JAM-A (fJAM-A) [8,9]. Both molecules
are important for cell entry, which is by clathrin-mediated
endocytosis and requires acidification of the endosome [40].
fJAM-A is the only protein receptor to be identified for any
member of the Caliciviridae. Experiments demonstrated that
transfection of the fJAM-A gene into non-permissive cells
rendered them susceptible to FCV infection, while antibodies
raised against fJAM-A blocked infection [8]. To investigate
the structural basis for fJAM-A receptor engagement, we
used cryogenic electron microscopy (cryoEM) combined with
computational three-dimensional image reconstruction to
determine the structure of purified FCV particles decorated
with a soluble fragment of fJAM-A (figure 1e–g) [36,41]. This
revealed that the fragment binds to the outer face of the
capsid P domain. Two fJAM-A molecules lie in a head-to-
tail arrangement about the twofold symmetry axis of each
VP1 dimer. Docking high-resolution coordinates for FCV
and fJAM-A—derived from crystallographic analysis and
homology modelling respectively—led to the synthesis of a
quasi-atomic resolution model of the receptor decorated
virion (figure 1h). This showed that the membrane-distal D1
domain was primarily responsible for the interaction, and
key residues in both virus and receptor that are involved in
viral attachment were identified (figure 1i). Interestingly, the
soluble fJAM-A fragment did not bind to the capsid in
the dimeric state seen in the structures of human and murine
forms solved by X-ray crystallography. The oligomeric state
of fJAM-A used in our study is not known; however, the site
of virus attachment to JAM-A does not suggest that viral bind-
ing would directly compete with the homodimer interaction.
The FCV-binding site on JAM-A resides in the beta-sheet com-
prising strands ABE while the homodimer interface is at the
opposite GFCC’ face. It may, however, be the case that bind-
ing to FCV disrupts the JAM-A homodimer by inducing a
structural change in the receptor.
In our study, substantial conformational changes in the viral
capsid protein were seen upon receptor binding. The P-domain
of the AB dimer was seen to rotate 158 counterclockwise, while
at the CC dimer the P-domain tilted away from the icosahedral
twofold symmetry axis. We hypothesize that these changes in
virion conformation may reflect the early stages of uncoating,
priming the capsid for subsequent genome release.
7. Picornavirus attachment
The Picornaviridae, like the Caliciviridae, are small icosahedral,
non-enveloped, positive-sense RNA-containing viruses. Many
Table 1. Diverse groups of viruses have been shown to bind to immunoglobulin-like superfamily cell-adhesion molecules to gain entry to the host cell. Both
DNA and RNA viruses exploit this class of molecules, as do enveloped and proteinaceous viruses.
virus receptor name abbreviation references
proteinaceous viruses
Adenoviridae
human adenovirus C coxsackievirus–adenovirus receptor CAR [25]
Caliciviridae
feline calicivirus junctional adhesion molecule A JAM-A [8]
Picornaviridae
coxsackie A virus type 21 intercellular adhesion molecule 1 ICAM-1/CD54 [26]
coxsackie B virus coxsackievirus–adenovirus receptor CAR [25]
encephalomyocarditis virus vascular cell-adhesion molecule 1 VCAM-1/CD106 [10]
major receptor group rhinovirus intercellular adhesion molecule 1 ICAM-1/CD54 [27]
poliovirus poliovirus receptor PVR/CD155 [28]
Reoviridae
reovirus junctional adhesion molecule A JAM-A [6]
enveloped viruses
Coronaviridae
mouse hepatitis virus carcinoembryonic antigen-related cell-adhesion molecule 1 CEACAM-1/CD66a [29]
Herpesviridae
herpes simplex virus nectin-1
nectin-2
HvecC/CD111
HvecB/CD112
[30,31]
Paramyxoviridae
measles virus nectin-4 [32]
Rhabdoviridae
rabiesvirus neuronal cell-adhesion molecule 1 NCAM-1/CD56 [33]
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viruses in this family have been found to have IgSFCAMrecep-
tors. Interestingly, these receptors also induce profound
conformational changes in the virion upon binding, destabiliz-
ing the capsid and leading to genome release. However, those
viruses that bind to non-IgSF receptors do not appear to
undergo such receptor-induced rearrangements.
Picornaviruses have generally well-conserved virion morph-
ology. The icosahedral capsid assembles from four structural
proteins designated VP1–4. VP1–3 occupy positions conven-
tionally taken by multiple copies of a single protein species
in a T ¼ 3 icosahedral lattice; thus picornaviruses are described
as pseudo T ¼ 3 or P3. Most picornaviruses have pronounced
star-shaped mesas at their icosahedral fivefold symmetry
axes that are surrounded by deep canyons (figure 2) [46].
CryoEM studies of picornavirus–CAM complexes show that
the tip of the membrane-distal Ig-like domain inserts into the
canyon such that the receptor is oriented more or less perpen-
dicular to the capsid surface [42,45]. This manner of receptor
engagement is rather different to that seen in FCV, which
binds to one side of the D1 domain. Surprisingly, however,
(a)
D E B A G
S-S
plasma membrane
F C C’ C”
(b)
(d) (e)
(f)
(h) (i)
(g)
(c)
Figure 1. The immunoglobulin superfamily of proteins are characterized as having domains of between seven and nine beta-strands arranged in two antiparallel
sheets that form a sandwich structure, stabilized by a conserved disulfide bridge (a; rainbow coloured from the N-terminus (blue) to the C-terminus (red)). The
crystal structure of a typical IgSF CAM—human JAM-A (b; PDB 1NBQ [34]) reveals that the two-domain molecule exists as a dimer in solution that is thought to
represent the native structure at tight junctions (c). The ribbon diagrams are rainbow coloured across two domains, hence the colours of individual strands in (b) and
(c) do not correspond to those in (a). Caliciviruses such as feline calicivirus (FCV) are RNA containing viruses that have a T ¼ 3 icosahedral capsid (d; PDB 3M8L)
[35]. This is composed of 180 capsid proteins (VP1) arranged as two classes of dimer: AB dimers (light and mid-blue) and CC dimers (dark blue). Cryo-electron
microscopy of FCV (e) decorated with a soluble fragment of feline JAM-A ( f ) reveals that the receptor binds to the tip of the protruding domain of VP1. Receptor
engagement induces conformational changes in the viral capsid such that the AB dimer rotates 158 anticlockwise and the CC dimer tilts away from the twofold
symmetry axis (g; arrows). Docking high-resolution coordinates to the three-dimensional reconstruction led to the calculation of a quasi-atomic resolution map of the
virus—receptor complex (h; FCV coloured blue, fJAM-A coloured magenta) that allowed the identification of putative contact residues (i). The VP1 AB dimer is
viewed from the virus exterior, fJAM molecules viewed as if peeled away from the capsid surface and rotated 180o [36]. Panels (d – i) are presented as wall-eyed
stereo pairs. (e– i) adapted from [36].
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detailed comparison of the interactions between picorna-
viruses and their respective IgSF CAM receptors revealed
that they bind to different faces of the D1 domain [47].
8. Evolution of virus– receptor interactions
Structural analysis of viral attachment proteins complexed to
Ig-like SF CAMs provides us with detailed descriptions of the
first step of the infectious process. In all cases studied so far,
the virus binds to the V-set membrane-distal D1 domain. It
has been suggested that viruses engage Ig-like SF molecules
in a manner that parallels immunoglobulin pathogen recog-
nition [48]. The above-mentioned comparison of interactions
in the Picornaviridae and our analysis of FCV JAM-A binding
are at odds with this, however, suggesting that viruses do
not exploit a common binding site. The FCV-binding site of
fJAM-A comprises residues in strands A, B and E, while entry
of reoviruses is mediated by an attachment protein s-1, which
engages the dimer interface of monomeric JAM-A at residues
in the C and C’ beta-strands (figure 3) [49]. Thus, opposite
faces of the D1 domain are required for entry of these two
viruses. In the case of reovirus attachment it is possible that
virus binding may directly disrupt JAM-A dimers.
Reo- and caliciviruses are quite distinct classes of viruses.
The Orthoreovirinae are large proteinaceous double-stranded
RNA containing viruses with a complex multi-layered
capsid. Protruding from each fivefold vertex are trimeric
fibres of the attachment protein s-1 that terminate in a globu-
lar knob domain comprising three beta-barrels. Evolution of
JAM-A and sialic acid binding in reo- and caliciviruses is
therefore most probably a product of convergent evolution.
The fact that IgSF CAM binding is widely observed in both
proteinaceous and enveloped viruses also argues that the
exploitation of such molecules is a highly advantageous
capability that has emerged repeatedly and independently.
Virus–receptor interactions in animal viruses are subject to
continual selective pressure in the face of immune surveillance.
A consequence of this is that the outer surfaces of virus par-
ticles are characterized by the presence of elaborate loop
structures and hypervariable regions that disrupt antibody-
mediated neutralization and serve to camouflage the more
highly conserved receptor-binding site. Under these circum-
stances it is likely that the binding site itself will nonetheless
undergo constant modification. It is easy to imagine how,
through mutation of the capsid or attachment proteins, the
receptor may ‘walk’ over the surface of the virus. Likewise,
the virus may, over time, evolve to bind a different face of
the receptor molecule or even to bind a different structurally
related molecule. Strong evidence for this can be seen in the
diverse interactions displayed by distantly related picorna-
viruses that bind to the complement control protein DAF.
DAF (also known as CD55) is not a member of the immuno-
globulin-like superfamily of proteins but displays a striking
divergence of binding modes by viruses that exploit it as a
receptor. In research published by ourselves and others,
cryoEM analysis of echovirus type 12 (EV12) and coxsackie
(a)
(b)
(c)
(d) (e)
Figure 2. Picornaviruses are small proteinaceous icosahedral viruses, many of
which have pronounced star-shaped mesas at their fivefold symmetry axes (a;
arrow) that are surrounded by canyons which contains the receptor-binding
sites for IgSF CAMs. Coxsackie B virus type 3 binds to the coxsackievirus and
adenovirus receptor (b; CAR domain 1 only is shown, figure generated using
PDB 1COV, 1KAC based on 1JEW [42–44]). Coxsackie A virus type 21 binds to
intercellular adhesion molecule 1 (ICAM-1) (c; PDB 1Z7Z [45]). Both molecules
are oriented perpendicular to the capsid surface. A close up view of the inter-
action (receptors shown as ribbon diagrams) shows that CAR (d ) and ICAM-1
(e) bind to the canyon in a similar but not identical orientation (fivefold sym-
metry axis indicated by a blue pentagon). (a– c) Stereoscopic views in which
virus is radially coloured blue-white and receptor is radially coloured
magenta-white. Panels (d ) and (e) are monoscopic and the virus surface is
shown in grey; the receptor is shown as a rainbow-coloured ribbon diagram.
(a)
(b)
Figure 3. (a,b) Views of the interaction between JAM-A (rainbow coloured)
and the reovirus attachment protein s-1 (magenta; wall-eyed stereo pairs—
PDB 3EOY, 1NBQ [34,49]).
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virus type B3 (CVB3) decorated with DAF revealed a marked
difference in the orientation of the receptor molecule on the
virion surface (figure 4) [50,51]. DAF comprises four short-con-
sensus repeat domains. CVB3 binding occurs primarily at
SCR2 while EV12 binds to SCR3. Moreover, there is a rotation
of almost 90o in the position of the DAFmolecule relative to the
capsid surface. It has been suggested that the differences
in DAF binding in these two viruses is the product of conver-
gent evolution to bind a common receptor. Given the high
mutation rates in RNA containing viruses and the above-
mentioned selective pressure, however, divergent evolution
from a common DAF binding ancestor would seem equally
or more plausible.
As we have seen, IgSF CAM binding occurs widely among
diverse classes of viruses, suggesting convergent evolution. On
the other hand,we can see howaprocess of continual evolution
in the face of immune surveillance may have led to diversifica-
tion of canyon-binding IgSF CAM interactions within the
Picornaviridae. Both convergent and divergent evolution of
this trait among different viruses argues that there is a strong
selective pressure to gain and retain a capability to bind these
molecules. As noted above, however, evidence for a conserved
binding motif is not compelling. Thus, the requirement to bind
to cell-adhesion molecules may originate in their functional
properties despite the apparent inconvenience of requiring the
virus to traffic across the cell surface to intercellular junctions to
effect cell entry. Recent research in this area is beginning to
provide insights into the possible reasons for the persistence
of this phenomenon.
9. Disruption of CAR homotypic interactions
leads to endocytosis
Group C adenoviruses bind to CAR in a manner that closely
parallels the reovirus JAM-A interaction. A trimeric fibre knob
protein engages the normally dimeric CARmolecule at an inter-
face that overlaps its dimerization site. The recent finding by
Salinas et al. [52] that disruption of the CARhomodimer by ade-
novirus fibre knob protein stimulates endocytosis provides
one possible explanation for the conservation of IgSF CAM
binding among diverse groups of viruses. Endocytosis is an
important aspect of IgSF CAM function, serving as a means
of intracellular signal transduction. Moreover, depletion of
CAMs from the cell surface is critical in regulation of cell
migration. Thus exploitation of this important functional
quality of IgSF CAMs could allow viruses to gain entry to the
cell interior. Several viruses that engage IgSF CAMs are, how-
ever, enveloped and postulated to enter by fusion at the
plasma membrane. Thus triggering endocytosis may not be
the sole reason for IgSF CAM usage, and further work is
necessary to establish whether those enveloped viruses
undergo endocytosis at intercellular junctions.
10. JAM-A facilitates dissemination of reovirus
infection
Much of our understanding of virus entry derives from
studies of viruses grown in cell culture. Our comprehension
of the complexities of virus behaviour within tissue or the
whole organism is therefore limited. To investigate the role
of JAM-A in reovirus infectious processes, Antar et al. [53]
investigated pathogenesis in JAM-A null mice. Animals
were perorally inoculated with a neurotropic strain of the
virus. The primary site of infection, the intestine, was infected
normally; however, JAM-A2/2 mice showed no sign of
neurological disease. In these studies, virus replication at
sites of secondary infection was significantly reduced as a
consequence of a failure of the virus to enter the blood-
stream. Neural spread was, however, unaffected. The authors
suggest that JAM-A plays a crucial role in establishment of
viraemia, either by facilitating infection of endothelial cells
leading to release of virus from apical cell surfaces into the
bloodstream or receptor-specific transcytosis of virus across
endothelial cells. An alternative hypothesis is that dissemin-
ation of virus through the bloodstream might be mediated
by infection of blood leucocytes.
11. Viral exploitation of IgSF proteins expressed
on cells of the immune system
In addition to the above-mentioned exploitation of IgSF
CAMs as viral receptors, there are several viruses that have
evolved specifically to infect cells of the immune system
through engagement of other IgSF molecules. These include
(a)
(b)
(c) (d)
Figure 4. Evolution of virus–receptor interactions. Coxsackie B virus type 3
(CVB3) binds to the complement control protein decay-accelerating factor
(DAF or CD55) at the apical cell surface prior to trafficking to tight junctions
where entry is mediated by the coxsackievirus and adenovirus receptor (CAR).
Comparison of the CVB3–DAF interaction (a; PDB 1COV, 3J24 [50]) with that
of the distantly related picornavirus echovirus type 12 (EV12) (b; PDB 2C8I
[51]) shows a markedly different receptor orientation. The structure is more
easily interpreted when only a single DAF molecule is shown. CVB3 (c)
binds primarily to domain 2 of DAF. EV12 binds predominantly domain 3
(d ); moreover, there is approximately 908 rotation in the orientation of the
two molecules on the capsid surface. These two viruses have quite different
receptor interactions but have probably evolved from a common DAF-binding
picornavirus ancestor. In each panel, the virus is radially coloured blue-white;
DAF-CD55 is radially coloured magenta-white.
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T-cell membrane protein 1 (TIM-1) which is bound by Ebola,
dengue and hepatitis A viruses [54–56], the HIV receptor
CD4 [57], and signalling lymphocyte-activation molecule
(SLAM) [58], which is exploited by measles virus. The ability
to infect migratory cells of the immune system is a strategy
that allows viral dissemination within the host without
danger of exposure to the adaptive immune response. It
seems plausible, then, that the viral strategy of infecting via
IgSF CAM mediated entry may also confer this advantage.
Immune cells display IgSF CAMs to mediate transmigration
through tissues. In the case of FCV and reovirus infection
of the respiratory and intestinal epithelium, respectively,
leucocytes responding to the viral attack may themselves
become infected and facilitate dissemination to secondary
sites of infection.
12. Summary
Many diverse groups of viruses bind to IgSF CAMs at the cell
surface tomediate cell entry. Structural analyses of virus recep-
tor complexes do not, however, indicate a common mode of
binding, suggesting that this phenomenon is not a simple
exploitation of the adhesive properties of these molecules.
Cell-adhesion molecules play a critical role in maintaining
tissue integrity and also mediating migration of immune
cells. This is achieved through control of surface expression
levels. Endocytosis of CAMs is the primary means of
modulating surface expression, and there is evidence that this
is mediated by disruption of the CAM homodimer interface.
Exploitation of this phenomenon by viruses to gain access to
the cell interior is a satisfying explanation for the IgSF CAM
binding phenotype. However, the exploitation of these recep-
tors by enveloped viruses that are thought to enter by fusion
at the plasma membrane argues against this being the sole
reason. Studies of reovirus infection in animal models show
that JAM-A is required for viral dissemination through
the bloodstream. It is postulated that this is related to the
expression of JAM-A on endothelial cells, which may allow
for transcytosis of virus into blood, or perhaps infection of
the endothelium may lead to apical release of virus into the
bloodstream. An alternative hypothesis is that IgSF CAM
expression allows for viral dissemination from sites of primary
infection in epithelial cells by transmission to responding
migratory cells of the immune system.
It is hoped that a detailed understanding of processes of
virus attachment and entry will provide researchers with
new targets for anti-viral development. In particular, mechan-
isms found to bewidespread among diverse groups of viruses,
such as entry via IgSF CAM binding, are appealing targets as
interventions have the potential for broad-spectrum activity.
As targeting host systems, such as regulation of cell adhesion
and immune cell transmigration, would seem to be a strategy
liable to significant toxicity, detailed dissection of the manner
in which viruses exploit these processes is critical.
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